Literature DB >> 9707217

Dural-pial arteriovenous malformation after sinus thrombosis.

T Ozawa1, Y Miyasaka, R Tanaka, A Kurata, K Fujii.   

Abstract

BACKGROUND: We report an unusual case of acquired dural-pial arteriovenous malformation (AVM) following sinus thrombosis. CASE DESCRIPTION: Initial angiography performed in a 39-year-old man showed thrombosis of the superior sagittal sinus (SSS) and the right transverse sinus (TS) but no vascular malformations. Follow-up angiography 29 months later revealed recanalization of the SSS and the TS, retrograde cortical venous drainage which suggested that thrombosis of the sinuses probably propagated into the adjacent parietal cortical veins, and development of a dural-pial AVM at or near the site of thrombi in more than one cortical vein. Complete surgical excision of the lesion was accomplished without neurological deterioration.
CONCLUSIONS: The present case suggests the possibility that the pial AVM is not only a congenital condition but also may develop as an acquired lesion.

Entities:  

Mesh:

Year:  1998        PMID: 9707217     DOI: 10.1161/01.str.29.8.1721

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  12 in total

1.  Multiple de novo vascular malformations in relation to diffuse venous occlusive disease: a case report.

Authors:  H A Desal; S K Lee; B S Kim; S Raoul; M Tymianski; K G TerBrugge
Journal:  Neuroradiology       Date:  2005-01-15       Impact factor: 2.804

2.  Infantile dural arteriovenous shunt draining into a developmental venous anomaly.

Authors:  S Geibprasert; T Krings; V Pereira; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2007-06-27       Impact factor: 1.610

3.  Clinical characteristics of dural arteriovenous shunts in 446 patients of three different ethnicities.

Authors:  S Geibprasert; T Krings; V Pereira; S Pongpech; R Piske; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2009-12-28       Impact factor: 1.610

4.  Cerebral arteriovenous fistulas induced by dural arteriovenous shunts.

Authors:  C W Lai; R Agid; R van den Berg; K Ter Brugge
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

Review 5.  Acquired pial arteriovenous fistula secondary to cerebral cortical vein thrombosis: A case report and review of the literature.

Authors:  Skander Sammoud; Nadia Hammami; Dhaker Turki; Fatma Nabli; Samia Ben Sassi; Samir Belal; Cyrine Drissi; Mohamed Ben Hamouda
Journal:  Neuroradiol J       Date:  2021-10-05

6.  Thrombophilia Due to Factor V and Factor II Mutations and Formation of a Dural Arteriovenous Fistula: Case Report and Review of a Rare Entity.

Authors:  Sam Safavi-Abbasi; Federico Di Rocco; Peter Nakaji; Guenther C Feigl; Alireza Gharabaghi; Madjid Samii; Anton Valavanis; Amir Samii
Journal:  Skull Base       Date:  2008-03

Review 7.  Documented development of a dural arteriovenous fistula in an infant subsequent to sinus thrombosis: case report and review of the literature.

Authors:  Humberto Morales; Blaise V Jones; James L Leach; Todd A Abruzzo
Journal:  Neuroradiology       Date:  2009-10-13       Impact factor: 2.804

Review 8.  'De Novo' Brain AVMs-Hypotheses for Development and a Systematic Review of Reported Cases.

Authors:  Ioan Alexandru Florian; Lehel Beni; Vlad Moisoiu; Teodora Larisa Timis; Ioan Stefan Florian; Adrian Balașa; Ioana Berindan-Neagoe
Journal:  Medicina (Kaunas)       Date:  2021-02-26       Impact factor: 2.430

9.  Coexistence of a Dural Arteriovenous Fistula and Pial Arteriovenous Malformation Sharing a Common Drainer.

Authors:  Kenji Uda; Takashi Izumi; Fumiaki Kanamori; Kinya Yokoyama; Tetsuya Tsukada; Masahiro Nishihori; Kazunori Shintai; Sho Okamoto; Yoshio Araki
Journal:  NMC Case Rep J       Date:  2021-08-26

Review 10.  Acquired pial and dural arteriovenous fistulae following superior sagittal sinus thrombosis in patients with protein S deficiency: a report of two cases.

Authors:  Shunji Matsubara; Koichi Satoh; Junichiro Satomi; Toshio Shigekiyo; Tomoya Kinouchi; Hajimu Miyake; Shinji Nagahiro
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-10-25       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.